Video

Using an App to Reduce Cancer-Related Anxiety

Author(s):

Joseph Greer, Ph.D.

​Joseph Greer, Ph.D., Clinical Director of Psychology and Research Scientist in the Center for Psychiatric Oncology & Behavioral Sciences at Massachusetts General Hospital, explains a mobile app to help anxiety in patients who have incurable cancer.

Joseph Greer, Ph.D., Clinical Director of Psychology and Research Scientist in the Center for Psychiatric Oncology & Behavioral Sciences at Massachusetts General Hospital, explains a mobile app to help anxiety in patients who have incurable cancer.

Patients diagnosed with an incurable cancer often see a decline in their quality of life (QOL) after the diagnosis. Greer and a team at Massachusetts General Hospital developed an app based on cognitive-behavioral therapy (CBT) intervention that had modules focusing on: relaxing the body, reducing worry, staying present-focused, improving communication and planning/pacing activities. After testing the app with 145 patients, researchers found that it led to significant improvements in anxiety.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Illustration of doctor.
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Related Content
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
April 11th 2025

What Role May ctDNA Have in Melanoma Management?

Dr. Michael K. Wong
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
March 6th 2025

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

Ryan Scott
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.
‘Jeopardy!’ Champion Christine Whelchel Recalls Why She Removed Her Wig on National TV
June 30th 2022

‘Jeopardy!’ Champion Christine Whelchel Recalls Why She Removed Her Wig on National TV

Sailaja Darisipudi Darlene Dobkowski, MA
In less than a year, Christine Whelchel went from receiving a diagnosis of breast cancer to becoming a trailblazing “Jeopardy!” champion.
Image of doctor with brown hair.
February 25th 2025

Some KRAS Mutations Associated With Worse Outcomes in Pancreatic Cancer

Dr. Vaia Florou
In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, researchers have found.
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.
February 21st 2025

How Patients With Cancer Can Avoid Counterfeit Therapeutics Online

Dr. Megan Menon
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.